{"id":517297,"date":"2021-07-26T07:03:25","date_gmt":"2021-07-26T11:03:25","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/renalytix-to-present-at-the-41st-annual-canaccord-genuity-global-growth-conference\/"},"modified":"2021-07-26T07:03:25","modified_gmt":"2021-07-26T11:03:25","slug":"renalytix-to-present-at-the-41st-annual-canaccord-genuity-global-growth-conference","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/renalytix-to-present-at-the-41st-annual-canaccord-genuity-global-growth-conference\/","title":{"rendered":"Renalytix to Present at the 41st Annual Canaccord Genuity Global Growth Conference"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"justify\">NEW YORK, July  26, 2021  (GLOBE NEWSWIRE) &#8212; Renalytix plc (LSE: RENX) (NASDAQ: RNLX) (\u201cRenalytix\u201d or the \u201cCompany\u201d) today announced the company will be presenting at the upcoming 41<sup>st<\/sup> Annual Canaccord Genuity Virtual Global Growth Conference.<\/p>\n<p align=\"justify\">Renalytix\u2019s management is scheduled to present at the Canaccord Genuity Global Growth Conference on Wednesday, August 11 at 2:30pm EDT. Interested parties may access a live and archived webcast of the presentations on the \u201cInvestors\u201d section of the company website at investors.renalytix.com.<\/p>\n<p>\n        <strong><br \/>\n          <em>For further information, please contact:<\/em><br \/>\n        <\/strong>\n      <\/p>\n<p>\n        <strong>UK Investor Contact:<\/strong>\n      <\/p>\n<table style=\"border-collapse: collapse;width:100%;border-collapse:collapse\">\n<tr>\n<td style=\"max-width:50%;width:50%;min-width:50%;vertical-align: top\">Walbrook PR\u00a0Limited<\/td>\n<td colspan=\"2\" style=\"max-width:50%;width:50%;min-width:50%;text-align: right;vertical-align: middle;vertical-align: top\">\n            <strong>Tel: 020 7933 8780 <\/strong>or\u00a0<a href=\"mailto:renalytix@walbrookpr.com\" rel=\"nofollow noopener\" target=\"_blank\"><u>renalytix@walbrookpr.com<\/u><\/a><\/td>\n<\/tr>\n<tr>\n<td colspan=\"2\" style=\"vertical-align: top\">Paul McManus \/ Lianne Cawthorne<\/td>\n<td style=\"text-align: right;vertical-align: middle;vertical-align: top\">Mob: 07980 541 893 \/ 07584 391 303<\/td>\n<\/tr>\n<\/table>\n<p>\n        <strong>US Investor Contact:<\/strong>\n      <\/p>\n<table style=\"border-collapse: collapse;width:100%;border-collapse:collapse\">\n<tr>\n<td style=\"max-width:50%;width:50%;min-width:50%;vertical-align: top\">Gilmartin Group<\/td>\n<td colspan=\"2\" style=\"max-width:50%;width:50%;min-width:50%;text-align: right;vertical-align: middle;vertical-align: top\">\n            <a href=\"mailto:investors@renalytix.com\" rel=\"nofollow noopener\" target=\"_blank\">investors@renalytix.com<\/a>\n          <\/td>\n<\/tr>\n<tr>\n<td colspan=\"2\" style=\"vertical-align: top\">Carrie Mendivil \/ Mary Kate McDonough<\/td>\n<td style=\"text-align: right;vertical-align: middle;vertical-align: top\">415-937-5405<\/td>\n<\/tr>\n<\/table>\n<p>\n        <strong>About Renalytix<br \/><\/strong>Renalytix is a developer of artificial intelligence-enabled clinical <em>in vitro<\/em> diagnostic solutions for kidney disease, one of the most common and costly chronic medical conditions globally. Renalytix&#8217;s products are being designed to make significant improvements in kidney disease diagnosis, transplant management, clinical care, patient stratification for drug clinical trials, and drug target discovery. For more information, visit <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=tJhl44_E8DYkvYfMoN4Su6kRMG6_42-_KcavkKjvAznd6N6wNnfF1Ixds_duYvh6h2AmSOWsmWKrTYOn08S-yg==\" rel=\"nofollow noopener\" target=\"_blank\">www.renalytix.com<\/a>.<\/p>\n<p>      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI4NTk3MyM0MzA4NDA0IzIyMDEwMjA=\" width=\"1\" height=\"1\" \/><br \/>\n      <br \/>\n      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/ml.globenewswire.com\/release\/track\/136acb50-8972-4d9b-92db-4c043cd63805\" width=\"1\" height=\"1\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>NEW YORK, July 26, 2021 (GLOBE NEWSWIRE) &#8212; Renalytix plc (LSE: RENX) (NASDAQ: RNLX) (\u201cRenalytix\u201d or the \u201cCompany\u201d) today announced the company will be presenting at the upcoming 41st Annual Canaccord Genuity Virtual Global Growth Conference. Renalytix\u2019s management is scheduled to present at the Canaccord Genuity Global Growth Conference on Wednesday, August 11 at 2:30pm EDT. Interested parties may access a live and archived webcast of the presentations on the \u201cInvestors\u201d section of the company website at investors.renalytix.com. For further information, please contact: UK Investor Contact: Walbrook PR\u00a0Limited Tel: 020 7933 8780 or\u00a0renalytix@walbrookpr.com Paul McManus \/ Lianne Cawthorne Mob: 07980 541 893 \/ 07584 391 303 US Investor Contact: Gilmartin Group investors@renalytix.com Carrie Mendivil \/ Mary Kate McDonough 415-937-5405 About &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/renalytix-to-present-at-the-41st-annual-canaccord-genuity-global-growth-conference\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Renalytix to Present at the 41st Annual Canaccord Genuity Global Growth Conference&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-517297","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Renalytix to Present at the 41st Annual Canaccord Genuity Global Growth Conference - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/renalytix-to-present-at-the-41st-annual-canaccord-genuity-global-growth-conference\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Renalytix to Present at the 41st Annual Canaccord Genuity Global Growth Conference - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"NEW YORK, July 26, 2021 (GLOBE NEWSWIRE) &#8212; Renalytix plc (LSE: RENX) (NASDAQ: RNLX) (\u201cRenalytix\u201d or the \u201cCompany\u201d) today announced the company will be presenting at the upcoming 41st Annual Canaccord Genuity Virtual Global Growth Conference. Renalytix\u2019s management is scheduled to present at the Canaccord Genuity Global Growth Conference on Wednesday, August 11 at 2:30pm EDT. Interested parties may access a live and archived webcast of the presentations on the \u201cInvestors\u201d section of the company website at investors.renalytix.com. For further information, please contact: UK Investor Contact: Walbrook PR\u00a0Limited Tel: 020 7933 8780 or\u00a0renalytix@walbrookpr.com Paul McManus \/ Lianne Cawthorne Mob: 07980 541 893 \/ 07584 391 303 US Investor Contact: Gilmartin Group investors@renalytix.com Carrie Mendivil \/ Mary Kate McDonough 415-937-5405 About &hellip; Continue reading &quot;Renalytix to Present at the 41st Annual Canaccord Genuity Global Growth Conference&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/renalytix-to-present-at-the-41st-annual-canaccord-genuity-global-growth-conference\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-07-26T11:03:25+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI4NTk3MyM0MzA4NDA0IzIyMDEwMjA=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/renalytix-to-present-at-the-41st-annual-canaccord-genuity-global-growth-conference\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/renalytix-to-present-at-the-41st-annual-canaccord-genuity-global-growth-conference\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Renalytix to Present at the 41st Annual Canaccord Genuity Global Growth Conference\",\"datePublished\":\"2021-07-26T11:03:25+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/renalytix-to-present-at-the-41st-annual-canaccord-genuity-global-growth-conference\\\/\"},\"wordCount\":188,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/renalytix-to-present-at-the-41st-annual-canaccord-genuity-global-growth-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODI4NTk3MyM0MzA4NDA0IzIyMDEwMjA=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/renalytix-to-present-at-the-41st-annual-canaccord-genuity-global-growth-conference\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/renalytix-to-present-at-the-41st-annual-canaccord-genuity-global-growth-conference\\\/\",\"name\":\"Renalytix to Present at the 41st Annual Canaccord Genuity Global Growth Conference - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/renalytix-to-present-at-the-41st-annual-canaccord-genuity-global-growth-conference\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/renalytix-to-present-at-the-41st-annual-canaccord-genuity-global-growth-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODI4NTk3MyM0MzA4NDA0IzIyMDEwMjA=\",\"datePublished\":\"2021-07-26T11:03:25+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/renalytix-to-present-at-the-41st-annual-canaccord-genuity-global-growth-conference\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/renalytix-to-present-at-the-41st-annual-canaccord-genuity-global-growth-conference\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/renalytix-to-present-at-the-41st-annual-canaccord-genuity-global-growth-conference\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODI4NTk3MyM0MzA4NDA0IzIyMDEwMjA=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODI4NTk3MyM0MzA4NDA0IzIyMDEwMjA=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/renalytix-to-present-at-the-41st-annual-canaccord-genuity-global-growth-conference\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Renalytix to Present at the 41st Annual Canaccord Genuity Global Growth Conference\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Renalytix to Present at the 41st Annual Canaccord Genuity Global Growth Conference - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/renalytix-to-present-at-the-41st-annual-canaccord-genuity-global-growth-conference\/","og_locale":"en_US","og_type":"article","og_title":"Renalytix to Present at the 41st Annual Canaccord Genuity Global Growth Conference - Market Newsdesk","og_description":"NEW YORK, July 26, 2021 (GLOBE NEWSWIRE) &#8212; Renalytix plc (LSE: RENX) (NASDAQ: RNLX) (\u201cRenalytix\u201d or the \u201cCompany\u201d) today announced the company will be presenting at the upcoming 41st Annual Canaccord Genuity Virtual Global Growth Conference. Renalytix\u2019s management is scheduled to present at the Canaccord Genuity Global Growth Conference on Wednesday, August 11 at 2:30pm EDT. Interested parties may access a live and archived webcast of the presentations on the \u201cInvestors\u201d section of the company website at investors.renalytix.com. For further information, please contact: UK Investor Contact: Walbrook PR\u00a0Limited Tel: 020 7933 8780 or\u00a0renalytix@walbrookpr.com Paul McManus \/ Lianne Cawthorne Mob: 07980 541 893 \/ 07584 391 303 US Investor Contact: Gilmartin Group investors@renalytix.com Carrie Mendivil \/ Mary Kate McDonough 415-937-5405 About &hellip; Continue reading \"Renalytix to Present at the 41st Annual Canaccord Genuity Global Growth Conference\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/renalytix-to-present-at-the-41st-annual-canaccord-genuity-global-growth-conference\/","og_site_name":"Market Newsdesk","article_published_time":"2021-07-26T11:03:25+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI4NTk3MyM0MzA4NDA0IzIyMDEwMjA=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/renalytix-to-present-at-the-41st-annual-canaccord-genuity-global-growth-conference\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/renalytix-to-present-at-the-41st-annual-canaccord-genuity-global-growth-conference\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Renalytix to Present at the 41st Annual Canaccord Genuity Global Growth Conference","datePublished":"2021-07-26T11:03:25+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/renalytix-to-present-at-the-41st-annual-canaccord-genuity-global-growth-conference\/"},"wordCount":188,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/renalytix-to-present-at-the-41st-annual-canaccord-genuity-global-growth-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI4NTk3MyM0MzA4NDA0IzIyMDEwMjA=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/renalytix-to-present-at-the-41st-annual-canaccord-genuity-global-growth-conference\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/renalytix-to-present-at-the-41st-annual-canaccord-genuity-global-growth-conference\/","name":"Renalytix to Present at the 41st Annual Canaccord Genuity Global Growth Conference - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/renalytix-to-present-at-the-41st-annual-canaccord-genuity-global-growth-conference\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/renalytix-to-present-at-the-41st-annual-canaccord-genuity-global-growth-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI4NTk3MyM0MzA4NDA0IzIyMDEwMjA=","datePublished":"2021-07-26T11:03:25+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/renalytix-to-present-at-the-41st-annual-canaccord-genuity-global-growth-conference\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/renalytix-to-present-at-the-41st-annual-canaccord-genuity-global-growth-conference\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/renalytix-to-present-at-the-41st-annual-canaccord-genuity-global-growth-conference\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI4NTk3MyM0MzA4NDA0IzIyMDEwMjA=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI4NTk3MyM0MzA4NDA0IzIyMDEwMjA="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/renalytix-to-present-at-the-41st-annual-canaccord-genuity-global-growth-conference\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Renalytix to Present at the 41st Annual Canaccord Genuity Global Growth Conference"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/517297","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=517297"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/517297\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=517297"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=517297"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=517297"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}